vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Finwise Bancorp (FINW). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $42.7M, roughly 1.1× Finwise Bancorp). Finwise Bancorp runs the higher net margin — 6.4% vs -19.9%, a 26.3% gap on every dollar of revenue. Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 47.0%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Finwise Bancorp is a U.S.-based financial holding company that operates primarily through its community banking subsidiary. It offers a full suite of retail and commercial financial services, including deposit accounts, personal loans, mortgage products, small business financing, and wealth management solutions, serving local retail consumers and small to medium-sized business clients across its regional operating markets.
ABCL vs FINW — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $42.7M |
| Net Profit | $-8.9M | $2.7M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | — |
| Net Margin | -19.9% | 6.4% |
| Revenue YoY | 788.4% | — |
| Net Profit YoY | 73.9% | — |
| EPS (diluted) | $-0.03 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $42.7M | ||
| Q4 25 | $44.9M | $46.9M | ||
| Q3 25 | $9.0M | $36.7M | ||
| Q2 25 | $17.1M | $25.1M | ||
| Q1 25 | $4.2M | $22.1M | ||
| Q4 24 | $5.0M | $21.1M | ||
| Q3 24 | $6.5M | $20.8M | ||
| Q2 24 | $7.3M | $19.8M |
| Q1 26 | — | $2.7M | ||
| Q4 25 | $-8.9M | $3.9M | ||
| Q3 25 | $-57.1M | $4.9M | ||
| Q2 25 | $-34.7M | $4.1M | ||
| Q1 25 | $-45.6M | $3.2M | ||
| Q4 24 | — | $2.8M | ||
| Q3 24 | $-51.1M | $3.5M | ||
| Q2 24 | $-36.9M | $3.2M |
| Q1 26 | — | — | ||
| Q4 25 | -63.7% | 11.7% | ||
| Q3 25 | -851.8% | 17.5% | ||
| Q2 25 | -290.2% | 21.7% | ||
| Q1 25 | -1479.6% | 20.1% | ||
| Q4 24 | — | 17.5% | ||
| Q3 24 | -1439.4% | 22.2% | ||
| Q2 24 | -1276.2% | 21.1% |
| Q1 26 | — | 6.4% | ||
| Q4 25 | -19.9% | 8.4% | ||
| Q3 25 | -637.8% | 13.3% | ||
| Q2 25 | -203.3% | 16.3% | ||
| Q1 25 | -1077.2% | 14.4% | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | -785.4% | 16.6% | ||
| Q2 24 | -504.3% | 16.1% |
| Q1 26 | — | $0.20 | ||
| Q4 25 | $-0.03 | $0.27 | ||
| Q3 25 | $-0.19 | $0.34 | ||
| Q2 25 | $-0.12 | $0.29 | ||
| Q1 25 | $-0.15 | $0.23 | ||
| Q4 24 | — | $0.19 | ||
| Q3 24 | $-0.17 | $0.25 | ||
| Q2 24 | $-0.13 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $196.6M |
| Total Assets | $1.4B | $899.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $128.5M | $163.4M | ||
| Q3 25 | $83.2M | $105.6M | ||
| Q2 25 | $92.4M | $90.1M | ||
| Q1 25 | $159.3M | $120.3M | ||
| Q4 24 | $156.3M | $109.2M | ||
| Q3 24 | $126.6M | $85.8M | ||
| Q2 24 | $148.3M | $89.0M |
| Q1 26 | — | $196.6M | ||
| Q4 25 | $966.9M | $193.2M | ||
| Q3 25 | $964.0M | $187.8M | ||
| Q2 25 | $1.0B | $182.0M | ||
| Q1 25 | $1.0B | $177.4M | ||
| Q4 24 | $1.1B | $173.7M | ||
| Q3 24 | $1.1B | $170.4M | ||
| Q2 24 | $1.1B | $165.8M |
| Q1 26 | — | $899.4M | ||
| Q4 25 | $1.4B | $977.1M | ||
| Q3 25 | $1.4B | $899.9M | ||
| Q2 25 | $1.4B | $842.5M | ||
| Q1 25 | $1.3B | $804.1M | ||
| Q4 24 | $1.4B | $746.0M | ||
| Q3 24 | $1.4B | $683.0M | ||
| Q2 24 | $1.4B | $617.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | — |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-34.7M | $-28.4M | ||
| Q3 25 | $-52.6M | $3.5M | ||
| Q2 25 | $-32.4M | $-18.3M | ||
| Q1 25 | $-11.6M | $-21.6M | ||
| Q4 24 | $-108.6M | $-15.0M | ||
| Q3 24 | $-28.9M | $-9.8M | ||
| Q2 24 | $-30.0M | $-7.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-44.6M | $-28.6M | ||
| Q3 25 | $-61.5M | $3.4M | ||
| Q2 25 | $-45.8M | $-19.8M | ||
| Q1 25 | $-22.2M | $-23.3M | ||
| Q4 24 | $-187.0M | $-16.1M | ||
| Q3 24 | $-47.4M | $-13.4M | ||
| Q2 24 | $-50.1M | $-7.7M |
| Q1 26 | — | — | ||
| Q4 25 | -99.4% | -61.1% | ||
| Q3 25 | -687.0% | 9.4% | ||
| Q2 25 | -267.9% | -79.0% | ||
| Q1 25 | -524.0% | -105.3% | ||
| Q4 24 | -3702.8% | -76.0% | ||
| Q3 24 | -728.4% | -64.3% | ||
| Q2 24 | -683.8% | -38.7% |
| Q1 26 | — | — | ||
| Q4 25 | 21.9% | 0.5% | ||
| Q3 25 | 99.7% | 0.1% | ||
| Q2 25 | 78.2% | 5.8% | ||
| Q1 25 | 251.1% | 7.4% | ||
| Q4 24 | 1552.7% | 5.1% | ||
| Q3 24 | 284.6% | 17.2% | ||
| Q2 24 | 274.6% | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | -7.26× | ||
| Q3 25 | — | 0.71× | ||
| Q2 25 | — | -4.48× | ||
| Q1 25 | — | -6.78× | ||
| Q4 24 | — | -5.37× | ||
| Q3 24 | — | -2.84× | ||
| Q2 24 | — | -2.39× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
FINW
| Net Interest Income | $28.1M | 66% |
| Noninterest Income | $14.6M | 34% |
